Hilton, T., Sanborn, R., Boulmay, B., Li, R., Spieler, B., Happel, K., Paustian, C., Moudgil, T., Dubay, C., Fisher, B., Mederos, E., Ochoa, A., Urba, W. J., Hu, H., & Fox, B. (n.d.). preliminary analysis of immune responses in patients enrolled in a Phase II trial of Cyclophosphamide with Allogenic DRibble Vaccine Alone (DPV-001) or with GM-CSF or Imiquimod for adjuvant treatment of Stage IIIA or IIIB NSCLC. Journal for immunotherapy of cancer, 2, . http://access.bl.uk/ark:/81055/vdc_100135547588.0x000001